Seminars in Oncology
Volume 33, Issue 5 , Pages 534-543 , October 2006

The Pathology of Renal Epithelial Neoplasms

  • Victor E. Reuter

      Affiliations

    • Corresponding Author InformationAddress correspondence to Victor E. Reuter, MD, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA.

References 

  1. Thöenes W, Storkel S, Rumpelt HJ. Human chromophobe cell renal carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol. 1985;48:207–217
  2. Thoenes W, Storkel S, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas) (The basic cytological and histopathological elements and their use for diagnostics). Pathol Res Pract. 1986;181:125–143
  3. Eble J, Sauter G, Epstein J, et al. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004;
  4. Kattan MW, Reuter V, Motzer RJ, et al. A postoperative prognostic nomogram for renal cell carcinoma. J Urol. 2001;166:63–67
  5. Sorbellini M, Kattan MW, Snyder ME, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol. 2005;173:48–51
  6. Amin MB, Tamboli P, Javidan J, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol. 2001;26:281–291
  7. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612–624
  8. Reuter VE, Presti JC. Contemporary approach to the classification of renal epithelial tumors. Semin Oncol. 2000;27:124–137
  9. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655–663
  10. Kovacs G, Erlandsson R, Boldog F, et al. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci U S A. 1988;85:1571–1575
  11. Carroll PR, Murty VV, Reuter V, et al. Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. Cancer Genet Cytogenet. 1987;26:253–259
  12. Nordenson I, Ljungberg B, Roos G. Chromosomes in renal carcinoma with reference to intratumor heterogeneity. Cancer Genet Cytogenet. 1988;32:35–41
  13. Walter TA, Berger CS, Sandberg AA. The cytogenetics of renal tumors (Where do we stand, where do we go?). Cancer Genet Cytogenet. 1989;43:15–34
  14. Teyssier JR, Ferre D. Chromosomal changes in renal cell carcinoma (No evidence for correlation with clinical stage). Cancer Genet Cytogenet. 1990;45:197–205
  15. Zbar B. Von Hippel-Lindau disease and sporadic renal cell carcinoma. Cancer Surv. 1995;25:219–232
  16. Linehan WM, Walther MM, Zbar B. The genetic basis of cancer of the kidney. J Urol. 2003;170:2163–2172
  17. Linehan WM. Molecular targeting of VHL gene pathway in clear cell kidney cancer. J Urol. 2003;170:593–594
  18. Pantuck AJ, Zeng G, Belldegrun AS, et al. Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: Exploiting the hypoxia-induced pathway. Clin Cancer Res. 2003;9:4641–4652
  19. Kim HL, Seligson D, Liu X, et al. Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res. 2004;10:5464–5471
  20. Bui MH, Seligson D, Han KR, et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy. Clin Cancer Res. 2003;9:802–811
  21. Delahunt B, Eble JN. Papillary renal cell carcinoma: A clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10:537–544
  22. Delahunt B, Eble JN, McCredie MR, et al. Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases. Hum Pathol. 2001;32:590–595
  23. Allory Y, Ouazana D, Boucher E, et al. Papillary renal cell carcinoma (Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases). Virchows Arch. 2003;442:336–342
  24. Jiang F, Richter J, Schraml P, et al. Chromosomal imbalances in papillary renal cell carcinoma: Genetic differences between histological subtypes. Am J Pathol. 1998;153:1467–1473
  25. Delahunt B, Eble JN, McCredie MR, et al. Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases. Hum Pathol. 2001;32:590–595
  26. Lubensky IA, Schmidt L, Zhuang Z, et al. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. Am J Pathol. 1999;155:517–526
  27. Reuter V, Tickoo SK. Adult renal tumors. In:  Reuter V editors. Sternberg’s Diagnostic Surgical Pathology. Philadelphia, PA: Lippincott Williams & Wilkins; 2004;p. 1955–1999
  28. Presti JC, Rao PH, Chen Q, et al. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res. 1991;51:1544–1552
  29. Yoshida MA, Ohyashiki K, Ochi H, et al. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res. 1986;46:2139–2147
  30. Schmidt L, Junker K, Nakaigawa N, et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene. 1999;18:2343–2350
  31. Dal Cin P, Gaeta J, Huben R, et al. Renal cortical tumors (Cytogenetic characterization). Am J Clin Pathol. 1989;92:408–414
  32. Kovacs G, Wilkens L, Papp T, et al. Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis. J Natl Cancer Inst. 1989;81:527–530
  33. Henn W, Zwergel T, Wullich B, et al. Bilateral multicentric papillary renal tumors with heteroclonal origin based on tissue-specific karyotype instability. Cancer. 1993;72:1315–1318
  34. Ishikawa I, Shikura N, Ozaki M. Papillary renal cell carcinoma with numeric changes of chromosomes in a long-term hemodialysis patient: A karyotype analysis. Am J Kidney Dis. 1993;21:553–556
  35. van den Berg E, van der Hout AH, Oosterhuis JW, et al. Cytogenetic analysis of epithelial renal-cell tumors: Relationship with a new histopathological classification. Int J Cancer. 1993;55:223–227
  36. de Jong B, Molenaar IM, Leeuw JA, et al. Cytogenetics of a renal adenocarcinoma in a 2-year-old child. Cancer Genet Cytogenet. 1986;21:165–169
  37. Shipley JM, Birdsall S, Clark J, et al. Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case. Cytogenet Cell Gener. 1995;71:280–284
  38. Sidhar SK, Clark J, Gill S, et al. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet. 1996;5:1333–1338
  39. Takahashi M, Kahnoski R, Gross D, et al. Familial adult renal neoplasia. J Med Genet. 2002;9:1–5
  40. Weterman MA, van Groningen JJ, den Hartog A, et al. Transformation capacities of the papillary renal cell carcinoma-associated PRCCTFE3 and TFE3PRCC fusion genes. Oncogene. 2001;20:1414–1424
  41. Weterman MA, van Groningen JJ, Tertoolen L, et al. Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas. Proc Natl Acad Sci U S A. 2001;98:13808–13813
  42. Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20:48–57
  43. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179–192
  44. Argani P, Lae M, Hutchinson B, et al. Renal Carcinomas With the t(6;11)(p21;q12): Clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol. 2005;29:230–240
  45. Thöenes W, Baum HP, Storkel S, et al. Cytoplasmic microvesicles in chromophobe cell renal carcinoma demonstrated by freeze fracture. Virchows Arch B Cell Pathol Incl Mol Pathol. 1987;54:127–130
  46. Thöenes W, Storkel S, Rumpelt HJ, et al. Chromophobe cell renal carcinoma and its variants—A report on 32 cases. J Pathol. 1988;155:277–287
  47. Storkel S, Steart PV, Drenckhahn D, et al. The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;56:237–245
  48. Akhtar M, Tulbah A, Kardar AH, et al. Sarcomatoid renal cell carcinoma: The chromophobe connection. Am J Surg Pathol. 1997;21:1188–1195
  49. Tickoo SK, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: Emphasis on technique and patterns of staining. Am J Surg Pathol. 1998;22:419–424
  50. Weiss LM, Gelb AB, Medeiros LJ. Adult renal epithelial neoplasms. Am J Clin Pathol. 1995;103:624–635
  51. Bugert P, Gaul C, Weber K, et al. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest. 1997;76:203–208
  52. Schwerdtle RF, Storkel S, Neuhaus C, et al. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma. Cancer Res. 1996;56:2927–2930
  53. Kovacs A, Kovacs G. Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosomes Cancer. 1992;4:267–268
  54. Akhtar M, Al-Sohaibani MO, Haleem A, et al. Flow cytometric DNA analysis of chrmophobe cell carcinoma of the kidney. J Urol Pathol. 1996;4:15–23
  55. Kovacs A, Storkel S, Thoenes W, et al. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas. J Pathol. 1992;167:273–277
  56. Crotty TB, Farrow GM, Lieber MM. Chromophobe cell renal carcinoma: Clinicopathological features of 50 cases. J Urol. 1995;154:964–967
  57. Motzer RJ, Bacik J, Mariani T, et al. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol. 2002;20:2376–2381
  58. Amin MB, Crotty TB, Tickoo SK, et al. Renal oncocytoma: A reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol. 1997;21:1–12
  59. Lieber MM, Tomera KM, Farrow GM. Renal oncocytoma. J Urol. 1981;125:481–485
  60. Perez-Ordonez B, Hamed G, Campbell S, et al. Renal oncocytoma: A clinicopathologic study of 70 cases. Am J Surg Pathol. 1997;21:871–883
  61. Tickoo SK, Amin MB. Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma: Analysis of their potential utility in the differential diagnosis. Am J Clin Pathol. 1998;110:782–787
  62. Tickoo SK, Lee MW, Eble JN, et al. Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol. 2000;24:1247–1256
  63. Erlandson RA, Shek TW, Reuter VE. Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: An ultrastructural study of 60 tumors. Ultrastruct Pathol. 1997;21:409–417
  64. Rumpelt HJ, Storkel S, Moll R, et al. Bellini duct carcinoma: Further evidence for this rare variant of renal cell carcinoma. Histopathology. 1991;18:115–122
  65. Singh I, Nabi G. Bellini duct carcinoma: Review of diagnosis and management. Int Urol Nephrol. 2002;34:91–95
  66. Füzesi L, Cober M, Mittermayer C. Collecting duct carcinoma: Cytogenetic characterization. Histopathology. 1992;21:155–160
  67. Adsay NV, deRoux SJ, Sakr W, et al. Cancer as a marker of genetic medical disease: An unusual case of medullary carcinoma of the kidney. Am J Surg Pathol. 1998;22:260–264
  68. Avery RA, Harris JE, Davis CJ, et al. Renal medullary carcinoma: Clinical and therapeutic aspects of a newly described tumor. Cancer. 1996;78:128–132
  69. Davis CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma (The seventh sickle cell nephropathy). Am J Surg Pathol. 1995;19:1–11
  70. Swartz MA, Karth J, Schneider DT, et al. Renal medullary carcinoma: Clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology. 2002;60:1083–1089
  71. Storkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma: Workgroup No. 1 (Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)). Cancer. 1997;80:987–989
  72. Zisman A, Chao DH, Pantuck AJ, et al. Unclassified renal cell carcinoma: Clinical features and prognostic impact of a new histological subtype. J Urol. 2002;168:950–955
  73. Bugert P, Kovacs G. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Am J Pathol. 1996;149:2081–2088
  74. Steiner G, Sidransky D. Molecular differential diagnosis of renal carcinoma: From microscopes to microsatellites. Am J Pathol. 1996;149:1791–1795
  75. Wagner JR, Linehan WM. Molecular genetics of renal cell carcinoma. Semin Urol Oncol. 1996;14:244–249
  76. Richards FM, Payne SJ, Zbar B, et al. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet. 1995;4:2139–2143
  77. Poston CD, Jaffe GS, Lubensky IA, et al. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: Clinical and molecular genetic implications. J Urol. 1995;153:22–26
  78. Linehan WM, Lerman MI, Zbar B. Identification of the von Hippel-Lindau (VHL) gene (Its role in renal cancer). JAMA. 1995;273:564–570
  79. Suzuki H, Ueda T, Komiya A, et al. Mutational state of von Hippel-Lindau and adenomatous polyposis coli genes in renal tumors. Oncology. 1997;54:252–257
  80. Zbar B, Tory K, Merino M, et al. Hereditary papillary renal cell carcinoma. J Urol. 1994;151:561–566
  81. Zbar B, Glenn G, Lubensky I, et al. Hereditary papillary renal cell carcinoma: Clinical studies in 10 families. J Urol. 1995;153:907–912
  82. King CR, Schimke RN, Arthur T, et al. Proximal 3p deletion in renal cell carcinoma cells from a patient with von Hippel-Lindau disease. Cancer Genet Cytogenet. 1987;27:345–348
  83. Jordan DK, Patil SR, Divelbiss JE, et al. Cytogenetic abnormalities in tumors of patients with von Hippel-Lindau disease. Cancer Genet Cytogenet. 1989;42:227–241
  84. Goodman MD, Goodman BK, Lubin MB, et al. Cytogenetic characterization of renal cell carcinoma in von Hippel-Lindau syndrome. Cancer. 1990;65:1150–1154
  85. Bodmer D, van den Hurk W, van Groningen JJ, et al. Understanding familial and non-familial renal cell cancer. Hum Mol Genet. 2002;11:2489–2498
  86. Schmidt L, Duh FM, Chen F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet. 1997;16:68–73
  87. Zbar B, Alvord WG, Glenn G, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome. Cancer Epidemiol Biomarkers Prev. 2002;11:393–400
  88. Khoo SK, Giraud S, Kahnoski K, et al. Clinical and genetic studies of Birt-Hogg-Dube syndrome. J Med Genet. 2002;39:906–912
  89. Pavlovich CP, Walther MM, Eyler RA, et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol. 2002;26:1542–1552
  90. Teh BT, Blennow E, Giraud S, et al. Bilateral multiple renal oncocytomas and cysts associated with a constitutional translocation (8;9)(q24.1;q34.3) and a rare constitutional VHL missense substitution. Genes Chromosomes Cancer. 1998;21:260–264
  91. Avery AK, Beckstead J, Renshaw AA, et al. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol. 2000;24:203–210
  92. McGregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma: The use of the monoclonal antibody ‘renal cell carcinoma marker’. Am J Surg Pathol. 2001;25:1485–1492
  93. Mathers ME, Pollock AM, Marsh C, et al. Cytokeratin 7: A useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology. 2002;40:563–567

PII: S0093-7754(06)00275-2

doi: 10.1053/j.seminoncol.2006.06.009

Seminars in Oncology
Volume 33, Issue 5 , Pages 534-543 , October 2006

Article Tools

* Image Usage & Resolution